Literature DB >> 26085877

The importance of urinary calcium in postmenopausal women with osteoporotic fracture.

Miguel Angel Ochoa-Hortal Rull1, María Del Carmen Cano-García2, Miguel Arrabal-Martín3, Miguel Angel Arrabal-Polo2.   

Abstract

INTRODUCTION: Calcium stones are associated with osteoporosis and manifested mainly by elevated fasting urinary calcium/creatinine ratio. The objective of this study is to demonstrate the presence of abnormal metabolism of calcium and calciuria in women with osteoporotic fracture with no previously known renal lithiasis compared to women without osteoporosis and without renal lithiasis.
METHODS: In total, 87 women were included in the study. They were divided into two groups: Group 1 with 55 postmenopausal women with osteoporotic fracture and without renal lithiasis; and Group 2 with 32 postmenopausal women without osteoporosis and without history of renal lithiasis. The following parameters of phospho-calcium metabolism were analyzed: calciuria 24-hour, oxaluria 24-hour, uricosuria 24-hour, and citraturia 24-hour. The presence of hypercalciuria, hyperoxaluria, hyperuricosuria, and hypocitraturia was compared between groups. Statistical significance was set at p ≤ 0.05.
RESULTS: The mean age was 70.1 ± 13.8 in Group 1 and 56.7 ± 6.4 in Group 2 (p = 0.0001). Women in Group 1 had higher levels of serum alkaline phosphatase (p < 0.05) and fasting urinary calcium/creatinine ratio (p < 0.05). The percentage of patients with hypercalciuria in Group 1 (40%) was higher compared to Group 2 (18.8%) and statistically significant (p = 0.04). There were no statistically significant differences in the percentage of hyperoxaluria, hyperuricosuria, and hypocitraturia between groups. This study has its limitations including its cross-sectional nature at a unique centre and its low number of patients.
CONCLUSION: The determination of urinary calcium and fasting calcium/creatinine ratio in postmenopausal women with osteoporotic fracture without renal lithiasis may facilitate individualization of medical therapy and decreasing lithogenic risk.

Entities:  

Year:  2015        PMID: 26085877      PMCID: PMC4455637          DOI: 10.5489/cuaj.2695

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  19 in total

Review 1.  Calcium supplementation in postmenopausal women to reduce the risk of osteoporotic fractures.

Authors:  Mikayla Spangler; Beth Bryles Phillips; Mary B Ross; Kevin G Moores
Journal:  Am J Health Syst Pharm       Date:  2011-02-15       Impact factor: 2.637

2.  Postmenopausal osteoporosis treatment and risk of urinary calculus development.

Authors:  Mohammad Reza Ganji
Journal:  Iran J Kidney Dis       Date:  2013-05       Impact factor: 0.892

3.  Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria.

Authors:  Emmanuel Letavernier; Olivier Traxer; Michel Daudon; Mohammed Tligui; Jérôme Hubert-Brierre; Dominique Guerrot; Aline Sebag; Laurent Baud; Jean-Philippe Haymann
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 8.237

Review 4.  Idiopathic hypercalciuria and bone health.

Authors:  Laura E Ryan; Steven W Ing
Journal:  Curr Osteoporos Rep       Date:  2012-12       Impact factor: 5.096

Review 5.  Calcium nephrolithiasis and bone demineralization: pathophysiology, diagnosis, and medical management.

Authors:  Miguel A Arrabal-Polo; María del Carmen Cano-García; Benjamin K Canales; Miguel Arrabal-Martín
Journal:  Curr Opin Urol       Date:  2014-11       Impact factor: 2.309

6.  Is the fasting calcium/creatinine a bone resorption marker in patients with calcium renal stones?

Authors:  Miguel Angel Arrabal-Polo; Miguel Arrabal-Martin; Antonio Poyatos-Andujar; Encarnacion Cardenas-Grande; Sergio Merino-Salas; Armando Zuluaga-Gomez
Journal:  Urol Res       Date:  2011-12-04

7.  Guidelines for the management of postmenopausal osteoporosis for GPs.

Authors:  Sheila O'Neill; Alastair MacLennan; Shona Bass; Terry Diamond; Peter Ebeling; David Findlay; Leon Flicker; Alex Markwell; Caryl Nowson; Nick Pocock; Philip Sambrook; Maria Fiatarone Singh
Journal:  Aust Fam Physician       Date:  2004-11

8.  Osteopenia/osteoporosis in patients with calcium nephrolithiasis.

Authors:  Miguel Angel Arrabal-Polo; Miguel Arrabal-Martin; Maria Sierra Girón-Prieto; Antonio Poyatos-Andujar; Juan Garrido-Gomez; Armando Zuluaga-Gomez; Salvador Arias-Santiago
Journal:  Urol Res       Date:  2012-08-12

9.  Vitamin D repletion does not alter urinary calcium excretion in healthy postmenopausal women.

Authors:  Kristina L Penniston; Andrea N Jones; Stephen Y Nakada; Karen E Hansen
Journal:  BJU Int       Date:  2009-04-15       Impact factor: 5.588

10.  Calcium and vitamin D supplementation and risk of kidney stone formation in postmenopausal women.

Authors:  Anousheh Haghighi; Hamidreza Samimagham; Golnar Gohardehi
Journal:  Iran J Kidney Dis       Date:  2013-05-21       Impact factor: 0.892

View more
  5 in total

1.  Bone remodeling markers as lithogenic risk factors in patients with osteopenia-osteoporosis.

Authors:  María Sierra Girón-Prieto; Salvador Arias-Santiago; María Del Carmen Cano-García; Antonio Poyatos-Andújar; Tomás de Haro-Muñoz; Felix Abad-Menor; Miguel Quesada-Charneco; Miguel Ángel Arrabal-Polo; Miguel Arrabal-Martín
Journal:  Int Urol Nephrol       Date:  2016-07-04       Impact factor: 2.370

2.  The variation in urinary calcium levels in adult patients with fracture and surgical intervention.

Authors:  Junfei Wang; Xin Zheng; Liming Zhang; Yifan Zhang; Jin Xiong; Yixin Cheng; Hongfei Shi; Xusheng Qiu; Leqin Zhou; Xizhao Sun
Journal:  J Orthop Surg Res       Date:  2017-08-15       Impact factor: 2.359

3.  A retrospective study of end-stage kidney disease patients on maintenance hemodialysis with renal osteodystrophy-associated fragility fractures.

Authors:  Lihua Xie; Xuantao Hu; Wenzhao Li; Zhengxiao Ouyang
Journal:  BMC Nephrol       Date:  2021-01-11       Impact factor: 2.388

4.  Urine and Serum Electrolytes and Biochemical Values Associated with Osteoporosis in Premenopausal and Postmenopausal Women: A Longitudinal and Cross-Sectional Study Using Korean Genome and Epidemiology Study (KoGES) Cohort.

Authors:  Hae-Sang Park; Ga-Young Kim; Jong-Ah Lo; Jin-Sun Kim; Shin-Young Ahn; Gang-Jee Ko; Young-Joo Kwon; Ji-Eun Kim
Journal:  J Clin Med       Date:  2021-05-17       Impact factor: 4.241

5.  Reduced hepcidin level features osteoporosis.

Authors:  Bin Liu; Caihua Liu; Weifeng Zhong; Min Song; Shouqin Du; Jianli Su
Journal:  Exp Ther Med       Date:  2018-07-05       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.